327 related articles for article (PubMed ID: 22421548)
1. Identification of residual risk factors for the development of venous thromboembolism in medical inpatients receiving subcutaneous heparin therapy for prophylaxis.
Kato S; Shimada YJ; Friedmann P; Kashan G; Husk G; Bergmann SR
Coron Artery Dis; 2012 Jun; 23(4):294-7. PubMed ID: 22421548
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
Pendergraft T; Liu X; Edelsberg J; Phatak H; Vera-Llonch M; Liu LZ; Oster G
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):75-82. PubMed ID: 23300270
[TBL] [Abstract][Full Text] [Related]
3. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism prophylaxis in hospitalized heart failure patients.
Jois-Bilowich P; Michota F; Bartholomew JR; Glauser J; Diercks D; Weber J; Fonarow GC; Emerman CL; Peacock WF;
J Card Fail; 2008 Mar; 14(2):127-32. PubMed ID: 18325459
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
Amin AN; Lin J; Lenhart G; Schulman KL
Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients.
Cook D; Attia J; Weaver B; McDonald E; Meade M; Crowther M
J Crit Care; 2000 Dec; 15(4):127-32. PubMed ID: 11138871
[TBL] [Abstract][Full Text] [Related]
8. Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma.
Haut ER; Lau BD; Kraenzlin FS; Hobson DB; Kraus PS; Carolan HT; Haider AH; Holzmueller CG; Efron DT; Pronovost PJ; Streiff MB
Arch Surg; 2012 Oct; 147(10):901-7. PubMed ID: 23070407
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the use of venous thromboembolism prophylaxis in hospitalised medical patients.
Panju M; Raso D; Patel A; Panju A; Ginsberg J
J R Coll Physicians Edinb; 2011 Dec; 41(4):304-8. PubMed ID: 22184567
[TBL] [Abstract][Full Text] [Related]
10. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
11. Incidence of hospital-acquired venous thromboembolic codes in medical patients hospitalized in academic medical centers.
Khanna R; Maynard G; Sadeghi B; Hensley L; Medvedev S; Danielsen B; White RH
J Hosp Med; 2014 Apr; 9(4):221-5. PubMed ID: 24497463
[TBL] [Abstract][Full Text] [Related]
12. [Venous thromboembolism prophylaxis in internal medicine].
Malý J; Widimský J; Dulícek P
Vnitr Lek; 2009 Mar; 55(3):190-5. PubMed ID: 19378845
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.
Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I;
Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897
[TBL] [Abstract][Full Text] [Related]
15. Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions.
Douketis JD
Curr Opin Pulm Med; 2008 Sep; 14(5):381-8. PubMed ID: 18664966
[TBL] [Abstract][Full Text] [Related]
16. [Frequency of venous thromboembolism among hospitalized patients with cancer].
Conte G; Figueroa G
Rev Med Chil; 2008 Dec; 136(12):1528-34. PubMed ID: 19350169
[TBL] [Abstract][Full Text] [Related]
17. Rates of venous thromboembolism occurrence in medical patients among the insured population.
Spyropoulos AC; Hussein M; Lin J; Battleman D
Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
[TBL] [Abstract][Full Text] [Related]
18. A validation study of a retrospective venous thromboembolism risk scoring method.
Bahl V; Hu HM; Henke PK; Wakefield TW; Campbell DA; Caprini JA
Ann Surg; 2010 Feb; 251(2):344-50. PubMed ID: 19779324
[TBL] [Abstract][Full Text] [Related]
19. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients.
Woller SC; Stevens SM; Jones JP; Lloyd JF; Evans RS; Aston VT; Elliott CG
Am J Med; 2011 Oct; 124(10):947-954.e2. PubMed ID: 21962315
[TBL] [Abstract][Full Text] [Related]
20. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study.
Gussoni G; Campanini M; Silingardi M; Scannapieco G; Mazzone A; Magni G; Valerio A; Iori I; Ageno W;
Thromb Haemost; 2009 May; 101(5):893-901. PubMed ID: 19404543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
